NO176242C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 5-substituerte ornithinderivater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive 5-substituerte ornithinderivater

Info

Publication number
NO176242C
NO176242C NO890455A NO890455A NO176242C NO 176242 C NO176242 C NO 176242C NO 890455 A NO890455 A NO 890455A NO 890455 A NO890455 A NO 890455A NO 176242 C NO176242 C NO 176242C
Authority
NO
Norway
Prior art keywords
therapeutically active
analogous process
preparing therapeutically
ornithine derivatives
substituted ornithine
Prior art date
Application number
NO890455A
Other languages
English (en)
Norwegian (no)
Other versions
NO890455L (no
NO176242B (no
NO890455D0 (no
Inventor
Fritz E Gerhart
Nikolaus Seiler
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO890455D0 publication Critical patent/NO890455D0/no
Publication of NO890455L publication Critical patent/NO890455L/no
Publication of NO176242B publication Critical patent/NO176242B/no
Publication of NO176242C publication Critical patent/NO176242C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/30Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
NO890455A 1988-02-05 1989-02-03 Analogifremgangsmåte for fremstilling av terapeutisk aktive 5-substituerte ornithinderivater NO176242C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88400275A EP0326766B1 (en) 1988-02-05 1988-02-05 5-substituted ornithine derivatives

Publications (4)

Publication Number Publication Date
NO890455D0 NO890455D0 (no) 1989-02-03
NO890455L NO890455L (no) 1989-08-07
NO176242B NO176242B (no) 1994-11-21
NO176242C true NO176242C (no) 1995-03-01

Family

ID=8200349

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890455A NO176242C (no) 1988-02-05 1989-02-03 Analogifremgangsmåte for fremstilling av terapeutisk aktive 5-substituerte ornithinderivater

Country Status (22)

Country Link
US (1) US4902719A (da)
EP (1) EP0326766B1 (da)
JP (1) JP2816431B2 (da)
KR (1) KR0150634B1 (da)
CN (1) CN1027891C (da)
AR (1) AR244657A1 (da)
AT (1) ATE77367T1 (da)
AU (1) AU612229B2 (da)
CA (1) CA1311767C (da)
DE (1) DE3872213T2 (da)
DK (1) DK172113B1 (da)
ES (1) ES2041815T3 (da)
FI (1) FI90530C (da)
GR (1) GR3005551T3 (da)
HU (1) HU204770B (da)
IE (1) IE63162B1 (da)
IL (1) IL89145A (da)
NO (1) NO176242C (da)
NZ (1) NZ227783A (da)
PH (1) PH26422A (da)
PT (1) PT89637B (da)
ZA (1) ZA89833B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69132363T2 (de) * 1990-04-26 2001-03-29 Procter & Gamble Chelat-zubereitung, die alpha-diamin-verbindungen enthalten
EP0609630A1 (en) * 1993-02-05 1994-08-10 Merrell Dow Pharmaceuticals Inc. Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of Alzheimer's disease
US5677350A (en) * 1995-06-07 1997-10-14 Wisconsin Alumni Research Foundation Inhibition of cancer cell growth, proliferation, and metastasis using N,N'-dα,ω-diaminoalkanes
GB9617822D0 (en) * 1996-08-27 1996-10-09 Lilly Industries Ltd Pharmaceutical compounds
US6566330B1 (en) 1996-10-22 2003-05-20 Medical University Of South Carolina Foundation Research Development Positively charged non-natural amino acids, methods of making and using thereof in peptides
US6043218A (en) 1996-10-22 2000-03-28 Medical University Of South Carolina Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
US7166234B1 (en) * 2000-10-26 2007-01-23 Integrated Biomedical Technology, Inc. Dialdehyde assay
US6911544B2 (en) * 2002-10-23 2005-06-28 Pfizer Inc. Process for the preparation of (S,S)-cis-2-phenyl-3-aminopiperidine
JP5994947B2 (ja) 2013-10-21 2016-09-21 富士電機株式会社 制御系設計支援装置、制御系設計支援プログラム、制御系設計支援方法、操作変化量算出装置および制御装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1091661A (en) * 1977-07-11 1980-12-16 Philippe Bey .alpha.-HALOMETHYL DERIVATIVES OF .alpha.-AMINO ACIDS
US4326071A (en) * 1977-09-28 1982-04-20 Merrell Toraude Et Compagnie Halomethyl derivatives of gamma-aminobutyric acid and related compounds
CA1174603A (en) * 1980-06-16 1984-09-18 Albert Sjoerdsma Method of inhibiting the growth of protozoa
US4668703A (en) * 1983-07-07 1987-05-26 Syntex (U.S.A.) Inc. γ-allenyl-γ-aminobutyric acids

Also Published As

Publication number Publication date
HU204770B (en) 1992-02-28
PT89637B (pt) 1994-02-28
FI890477A (fi) 1989-08-06
PT89637A (pt) 1989-10-04
FI890477A0 (fi) 1989-02-01
KR0150634B1 (ko) 1998-10-15
DK172113B1 (da) 1997-11-10
CA1311767C (en) 1992-12-22
ZA89833B (en) 1989-10-25
AU2951589A (en) 1989-08-10
EP0326766B1 (en) 1992-06-17
IE63162B1 (en) 1995-03-22
DK51589A (da) 1989-08-06
HUT49320A (en) 1989-09-28
IL89145A (en) 1993-08-18
ES2041815T3 (es) 1993-12-01
ATE77367T1 (de) 1992-07-15
FI90530B (fi) 1993-11-15
EP0326766A1 (en) 1989-08-09
NO890455L (no) 1989-08-07
CN1027891C (zh) 1995-03-15
NZ227783A (en) 1990-12-21
KR890012942A (ko) 1989-09-20
IL89145A0 (en) 1989-09-10
DE3872213D1 (de) 1992-07-23
DK51589D0 (da) 1989-02-03
GR3005551T3 (da) 1993-06-07
PH26422A (en) 1992-07-15
JPH021435A (ja) 1990-01-05
CN1037142A (zh) 1989-11-15
IE890356L (en) 1989-08-05
NO176242B (no) 1994-11-21
US4902719A (en) 1990-02-20
NO890455D0 (no) 1989-02-03
AU612229B2 (en) 1991-07-04
JP2816431B2 (ja) 1998-10-27
AR244657A1 (es) 1993-11-30
DE3872213T2 (de) 1993-01-28
FI90530C (fi) 1994-02-25

Similar Documents

Publication Publication Date Title
NO176759C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
NO180586C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte imidazoler
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO177387C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive imidazo-kondenserte, 6-leddede, heterocykliske forbindelser
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
NO179283C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler
NO180749C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolsubstituerte derivater
NO174467C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
FI96601C (fi) Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi
NO175429C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive 16-dehydro-vitamin-D3-derivater
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
NO175528C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive fenylacetamid-derivater
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO178967C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazin-derivater
NO176142C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminoalkoksyfenylderivater
NO174391C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO176100C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater
NO176477C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-alkoksymetylsubstituerte kromanderivater
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
NO174422C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO174200C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser
NO176242C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 5-substituerte ornithinderivater